New research could help find a therapy to treat COVID-19
Researchers from the Technical University of Munich have successfully used specific enzymes to destroy the genetic information of SARS-CoV-2 directly after the virus enters a cell.
List view / Grid view
Researchers from the Technical University of Munich have successfully used specific enzymes to destroy the genetic information of SARS-CoV-2 directly after the virus enters a cell.
Researchers have developed a new way to generate breast tumour models faster, more reliably and with less immune variability than existing models.
Researchers have developed a new imaging approach that can capture blood vessel images at different spatial scales.
A study has shown how Parkinson’s disease may be driven by cell stress-related biochemical events that disrupt a key cellular clean-up system.
MIT chemists have discovered a possible way to design drugs that could fight against drug resistance.
Researchers have identified potential age-related macular degeneration drugs using a novel stem-cell based research tool.
New research by the University of California, San Diego could provide a much simpler way to repair disease-causing mutations in RNA.
Researchers have made a respiratory model of COVID-19, made from patient-derived stem cells, to understand how the virus affects respiration and which could be used to test possible drugs.
Using virtual screening, researchers have discovered several natural compounds that could inhibit the SARS-CoV-2 main protease.
A research team based at Skoltech in Russia has developed an artificial intelligence-driven solution for highly accurate detection of efficacious binding sites to expedite drug discovery.
A new platform, named Virtual Synthon Hierarchical Enumeration Screening, has been developed by researchers to efficiently discover drugs.
19 August 2021 | By 10X Genomics
Explore the latest developments in screening technologies and how drug discovery has changed during the past decades in our webinar with 10X Genomics.
11 May 2021 | By PerkinElmer
Get the Big Picture and listen to Pharma thought leaders how they view CETSA® and its impact on their Drug Discovery.
New research has shown that 'hidden' lysis genes in bacteriophages could be used in the development of a new class of antibiotics.
Scientists have created a drug discovery platform that enables the discovery and optimisation of RNA-targeting compounds.